Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Altun I, Sonkaya A (2018) The most common side effects experienced by patients were receiving first cycle of chemotherapy. Iran J Public Health 47(8):1218–1219
2. Panda M, Biswal BK (2019) Cell signaling and cancer: a mechanistic insight into drug resistance.Molecular biology reports. :1–15
3. Zheng X, Oancea C, Henschler R, Ruthardt M (2009) Cooperation between constitutively activated c-Kit signaling and leukemogenic transcription factors in the determination of the leukemic phenotype in murine hematopoietic stem cells. Int J Oncol 34(6):1521–1531
4. Steelman L, Pohnert S, Shelton J, Franklin R, Bertrand F, McCubrey J, JAK/STAT (2004) Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 18(2):189–218
5. Tafuri A, Milella M, Iacovelli S, De Cave F, Gregorj C, Bergamo P, Miele A, Licchetta R, Konopleva M, McCubrey JA (2011) Aberrant proliferative and apoptotic pathways in acute lymphoblastic leukemia (ALL): Molecular therapies to overcome chemo-resistance.Novel aspects in acute lymphoblastic leukemia Rijeka, Croatia: InTech. :183–210